DK135711B - Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer. - Google Patents
Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer.Info
- Publication number
- DK135711B DK135711B DK53975AA DK53975A DK135711B DK 135711 B DK135711 B DK 135711B DK 53975A A DK53975A A DK 53975AA DK 53975 A DK53975 A DK 53975A DK 135711 B DK135711 B DK 135711B
- Authority
- DK
- Denmark
- Prior art keywords
- phenoxyisopropanolamines
- preparation
- analogous process
- active substituted
- novel cardiac
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7401958A SE388849B (sv) | 1974-02-14 | 1974-02-14 | Forfarande for framstellning av nya aminer med beta-receptorstimulerande verkan |
Publications (3)
Publication Number | Publication Date |
---|---|
DK53975A DK53975A (ko) | 1975-10-06 |
DK135711B true DK135711B (da) | 1977-06-13 |
DK135711C DK135711C (ko) | 1977-11-21 |
Family
ID=20320208
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK53975AA DK135711B (da) | 1974-02-14 | 1975-02-14 | Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer. |
Country Status (23)
Country | Link |
---|---|
US (2) | US4244969A (ko) |
JP (1) | JPS50116433A (ko) |
AT (1) | AT334881B (ko) |
AU (1) | AU497441B2 (ko) |
BE (1) | BE825515A (ko) |
CA (1) | CA1052387A (ko) |
CH (1) | CH616648A5 (ko) |
CS (2) | CS202035B2 (ko) |
DD (1) | DD118614A5 (ko) |
DE (1) | DE2502993A1 (ko) |
DK (1) | DK135711B (ko) |
FI (1) | FI62055B (ko) |
FR (1) | FR2261000B1 (ko) |
GB (1) | GB1492647A (ko) |
HU (1) | HU169704B (ko) |
IE (1) | IE41350B1 (ko) |
IT (1) | IT7950875A0 (ko) |
LU (1) | LU71846A1 (ko) |
NL (1) | NL7501785A (ko) |
NO (1) | NO140628C (ko) |
SE (1) | SE388849B (ko) |
SU (3) | SU603332A3 (ko) |
ZA (1) | ZA75381B (ko) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4210653A (en) * | 1978-06-27 | 1980-07-01 | Merck & Co., Inc. | Pyridyloxypropanolamines |
SE8004088L (sv) | 1980-06-02 | 1981-12-03 | Haessle Ab | Nya substituerade 3-fenoxi-l-alkoxikarbonylalkylamino-propanol-2-er med beta-receptorblockerande egenskaper samt forfarande for deras framstellning, farmaceutiska beredningar innehallande desamma och metod att ... |
US4396629A (en) * | 1980-12-29 | 1983-08-02 | Sterling Drug Inc. | Compositions, processes and method |
US5166218A (en) * | 1983-10-19 | 1992-11-24 | Hoffmann-La Roche Inc. | Phenoxypropanolamines and pharmaceutical compositions thereof |
CA1262729A (en) * | 1983-10-19 | 1989-11-07 | Leo Alig | Phenoxypropanolamines |
SE457505B (sv) * | 1984-01-10 | 1989-01-09 | Lejus Medical Ab | Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning |
DE3544172A1 (de) * | 1985-12-13 | 1987-06-19 | Lentia Gmbh | Neue kristalline salze von aryloxy-propanolaminen, verfahren zu ihrer herstellung und ihre verwendung |
DE3773188D1 (de) * | 1987-03-26 | 1991-10-24 | Helopharm Petrik Co Kg | Verfahren zur herstellung von 5-hydroxydiprafenon und seiner salze mit saeuren. |
WO1997037967A1 (en) | 1996-04-09 | 1997-10-16 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
US6818660B2 (en) | 1996-04-09 | 2004-11-16 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
US5966498A (en) * | 1996-08-07 | 1999-10-12 | Lakewood Engineering And Manufacturing Company | End closure assembly for oil-filled heater |
TW483881B (en) | 1996-12-03 | 2002-04-21 | Nps Pharma Inc | Calcilytic compounds |
US7202261B2 (en) | 1996-12-03 | 2007-04-10 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
JP4604583B2 (ja) * | 2004-07-20 | 2011-01-05 | ダイソー株式会社 | 1−アミド−3−(2−ヒドロキシフェノキシ)−2−プロパノール誘導体、ならびに2−アミドメチル−1,4−ベンゾジオキサン誘導体の製造法 |
IL165365A0 (en) | 2004-11-24 | 2006-01-15 | Q Core Ltd | Finger-type peristaltic pump |
JP4934287B2 (ja) * | 2005-04-05 | 2012-05-16 | 花王株式会社 | 美白剤 |
FR2916441B1 (fr) * | 2007-05-22 | 2009-08-28 | Clariant Specialty Fine Chem | Procede de racemisation d'alpha-aminoacetals optiquement actifs. |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL301580A (ko) * | 1962-12-11 | |||
GB1069345A (en) * | 1963-07-19 | 1967-05-17 | Ici Ltd | New alkanolamine derivatives |
DE1922003C3 (de) * | 1969-04-30 | 1979-10-11 | Boehringer Mannheim Gmbh, 6800 Mannheim | N-(3-Aryloxy-2-hydroxypropyl)-aminocarbonsäuren, deren Ester, Amide und Salze, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung bei der Bekämpfung von Herzinsuffizienz |
BE790165A (fr) * | 1971-12-14 | 1973-02-15 | Parke Davis & Co | Nouveaux aminoalcanols et procede pour les preparer |
-
1974
- 1974-02-14 SE SE7401958A patent/SE388849B/xx unknown
-
1975
- 1975-01-20 ZA ZA00750381A patent/ZA75381B/xx unknown
- 1975-01-25 DE DE19752502993 patent/DE2502993A1/de not_active Ceased
- 1975-02-10 AT AT96475*#A patent/AT334881B/de not_active IP Right Cessation
- 1975-02-12 SU SU752104405A patent/SU603332A3/ru active
- 1975-02-12 AU AU78116/75A patent/AU497441B2/en not_active Expired
- 1975-02-12 FI FI750390A patent/FI62055B/fi not_active Application Discontinuation
- 1975-02-12 DD DD184143A patent/DD118614A5/xx unknown
- 1975-02-12 CH CH169075A patent/CH616648A5/de not_active IP Right Cessation
- 1975-02-13 NO NO750468A patent/NO140628C/no unknown
- 1975-02-13 IE IE279/75A patent/IE41350B1/xx unknown
- 1975-02-13 GB GB6172/75A patent/GB1492647A/en not_active Expired
- 1975-02-13 CA CA220,014A patent/CA1052387A/en not_active Expired
- 1975-02-13 FR FR7504553A patent/FR2261000B1/fr not_active Expired
- 1975-02-13 US US05/549,841 patent/US4244969A/en not_active Expired - Lifetime
- 1975-02-13 HU HUHE678A patent/HU169704B/hu unknown
- 1975-02-14 CS CS75986A patent/CS202035B2/cs unknown
- 1975-02-14 JP JP50018088A patent/JPS50116433A/ja active Pending
- 1975-02-14 DK DK53975AA patent/DK135711B/da unknown
- 1975-02-14 NL NL7501785A patent/NL7501785A/xx not_active Application Discontinuation
- 1975-02-14 BE BE153340A patent/BE825515A/xx unknown
- 1975-02-14 LU LU71846A patent/LU71846A1/xx unknown
-
1976
- 1976-01-20 SU SU762315654A patent/SU609460A3/ru active
- 1976-01-23 SU SU7602314963A patent/SU577971A3/ru active
-
1978
- 1978-08-28 CS CS785579A patent/CS202036B2/cs unknown
-
1979
- 1979-11-21 IT IT7950875A patent/IT7950875A0/it unknown
-
1980
- 1980-05-19 US US06/150,883 patent/US4336267A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
LU71846A1 (ko) | 1975-12-09 |
CS202035B2 (en) | 1980-12-31 |
NO750468L (ko) | 1975-08-15 |
ZA75381B (en) | 1976-01-28 |
FR2261000B1 (ko) | 1978-07-21 |
SU603332A3 (ru) | 1978-04-15 |
DD118614A5 (ko) | 1976-03-12 |
US4244969A (en) | 1981-01-13 |
ATA96475A (de) | 1976-06-15 |
AT334881B (de) | 1977-02-10 |
US4336267A (en) | 1982-06-22 |
GB1492647A (en) | 1977-11-23 |
SE7401958L (ko) | 1975-08-15 |
AU497441B2 (en) | 1978-12-14 |
AU7811675A (en) | 1976-08-12 |
JPS50116433A (ko) | 1975-09-11 |
DE2502993A1 (de) | 1975-09-04 |
IT7950875A0 (it) | 1979-11-21 |
FI62055B (fi) | 1982-07-30 |
NO140628C (no) | 1979-10-10 |
HU169704B (ko) | 1977-02-28 |
IE41350B1 (en) | 1979-12-19 |
NL7501785A (nl) | 1975-08-18 |
NO140628B (no) | 1979-07-02 |
SU609460A3 (ru) | 1978-05-30 |
DK53975A (ko) | 1975-10-06 |
BE825515A (fr) | 1975-08-14 |
CA1052387A (en) | 1979-04-10 |
DK135711C (ko) | 1977-11-21 |
IE41350L (en) | 1975-08-14 |
CS202036B2 (en) | 1980-12-31 |
FR2261000A1 (ko) | 1975-09-12 |
SE388849B (sv) | 1976-10-18 |
SU577971A3 (ru) | 1977-10-25 |
CH616648A5 (ko) | 1980-04-15 |
FI750390A (ko) | 1975-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK136718B (da) | Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyran-9-oner. | |
DK136719B (da) | Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner. | |
DK136075B (da) | Analogifremgangsmåde til fremstilling af 11beta-hydroxy-16-methyl-3-oxo-17alfa-acyloxyandrosta-1,4,15-trien-17beta-carboxylater. | |
DK135711B (da) | Analogifremgangsmåde til fremstilling af hidtil ukendte, hjerteaktive substituerede fenoxyisopropanolaminer. | |
DK137835B (da) | Analogifremgangsmåde til fremstilling af thienothiazinderivater. | |
DK139678B (da) | Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin. | |
DK139846B (da) | Analogifremgangsmåde til fremstilling af 3-alkoxypyrazin-2-carboxamider. | |
DK135796B (da) | Fremgangsmåde til fremstilling af alkyl-tert-alkylethere. | |
DK138321B (da) | Analogifremgangsmåde til fremstilling af 5-halogen-2,3-kresotinsyrederivater. | |
DK140406B (da) | Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin. | |
DK137389B (da) | Analogifremgangsmåde til fremstilling af 11beta-substituerede delta4-østrener. | |
DK136529B (da) | Analogifremgangsmåde til fremstilling af benzofuranderivater. | |
DK135723B (da) | Analogifremgangsmåde til fremstilling af 7alfa-acylthio-3-oxo-D-homo-21,24-dinor-17aalfa-chlo-4-en-23,17a-lactoner. | |
DK132328B (da) | Analogifremgangsmåde til fremstilling af 17beta-hydroxy-16,16-dimethylestr-4-en-3-on. | |
DK139682B (da) | Analogifremgangsmåde til fremstilling af eburnameninderivater. | |
DK135167B (da) | Analogifremgangsmåde til fremstilling af 7,7'-ditheophyllinderivater. | |
DK137043B (da) | Analogifremgangsmåde til fremstilling af nitrocarbostyrilforbindelser. | |
DK137449B (da) | Fremgangsmåde til fremstilling af N,N-diallyldichloracetamid. | |
DK138694B (da) | Fremgangsmåde til fremstilling af phenylphosphonothiodichlorid. | |
DK140670B (da) | Analogifremgangsmåde til fremstilling af ergopeptinderivater. | |
DK137646B (da) | Fremgangsmåde til fremstilling af 6-chlor-2-chlormethyl-4-phenylquinazolin-3-oxid. | |
DK138499B (da) | Fremgangsmåde til fremstilling af 11beta-hydroksy-18-alkyløstranforbindelser. | |
DK136619B (da) | Fremgangsmåde til fremstilling af dihydrokanadensolid. | |
DK136652B (da) | Fremgangsmåde til fremstilling af thieno-pyridinderivater. | |
DK140313B (da) | Analogifremgangsmåde til fremstilling af 1-sulfonyl-5(6)-substitueret-benzimidazoler. |